Breast cell line dose response to target inhibition measured by high throughput microscopy - Dataset (ID:20136)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Units | Timepoint | Timepoint Units | Measured pERK (Alexa 488) | Measured p-Rb (Alexa 568) | Alexa Fluor 647 | Measured p-Akt/p-4EBP1/p-S6 (Alexa 647) | Image |
---|---|---|---|---|---|---|---|---|---|---|
Torkinib | MCF 10A | 0.1 | nM | 24 | hr | 342.29 | 124.00 | p-Akt | 50.29 | |
GSK1059615 | MCF 10A | 1.0 | nM | 6 | hr | 470.40 | 164.01 | p-Akt | 53.70 | |
GSK1059615 | MCF 10A | 1.0 | nM | 24 | hr | 382.76 | 126.38 | p-Akt | 50.94 | |
MK2206 | MCF 10A | 1.0 | nM | 6 | hr | 436.98 | 158.45 | p-Akt | 51.09 | |
MK2206 | MCF 10A | 1.0 | nM | 24 | hr | 309.88 | 125.31 | p-Akt | 42.87 | |
Triciribine | MCF 10A | 1.0 | nM | 6 | hr | 439.88 | 158.37 | p-Akt | 51.51 | |
Triciribine | MCF 10A | 1.0 | nM | 24 | hr | 311.02 | 118.46 | p-Akt | 43.92 | |
Dactolisib | MCF 10A | 1.0 | nM | 6 | hr | 437.12 | 174.36 | p-Akt | 52.90 | |
Dactolisib | MCF 10A | 1.0 | nM | 24 | hr | 332.80 | 131.47 | p-Akt | 43.15 | |
Gefitinib | T47D | 1.0 | nM | 6 | hr | 174.36 | 98.22 | p-Akt | 105.50 | |
Gefitinib | T47D | 1.0 | nM | 24 | hr | 158.15 | 112.49 | p-Akt | 78.61 | |
Torkinib | T47D | 0.1 | nM | 6 | hr | 173.65 | 92.27 | p-Akt | 90.58 | |
Torkinib | T47D | 0.1 | nM | 24 | hr | 159.19 | 92.25 | p-Akt | 63.92 | |
GSK1059615 | T47D | 1.0 | nM | 6 | hr | 177.09 | 87.31 | p-Akt | 93.26 | |
GSK1059615 | T47D | 1.0 | nM | 24 | hr | 163.58 | 90.72 | p-Akt | 66.78 | |
MK2206 | T47D | 1.0 | nM | 6 | hr | 94.42 | 35.53 | p-Akt | 13.06 | |
MK2206 | T47D | 1.0 | nM | 24 | hr | 161.37 | 97.31 | p-Akt | 58.78 | |
Triciribine | T47D | 1.0 | nM | 6 | hr | 96.98 | 46.31 | p-Akt | 19.11 | |
Triciribine | T47D | 1.0 | nM | 24 | hr | 146.78 | 89.33 | p-Akt | 59.46 | |
Dactolisib | T47D | 1.0 | nM | 6 | hr | 90.24 | 35.16 | p-Akt | 13.70 | |
Dactolisib | T47D | 1.0 | nM | 24 | hr | 138.24 | 90.29 | p-Akt | 47.16 | |
Gefitinib | AU565 | 3.16 | nM | 6 | hr | 308.09 | 68.07 | p-Akt | 33.62 | |
Gefitinib | AU565 | 3.16 | nM | 24 | hr | 586.23 | 125.39 | p-Akt | 136.14 | |
Torkinib | AU565 | 0.422 | nM | 6 | hr | 269.85 | 59.34 | p-Akt | 25.74 | |
Torkinib | AU565 | 0.422 | nM | 24 | hr | 481.77 | 110.68 | p-Akt | 88.17 |